Daniel Starks

American businessperson and board member, Retired Chairman, President and CEO, St. Jude Medical, Inc.; director at Abbott Laboratories.¹

Companies

Abbott LaboratoriesBoard member 2017 to now⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Abbott Laboratories ABT6,751,361 shares⁸$706.9M at $104.71Apr 28, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 27, 2026Bought 10,000 shares at $92.65 of Abbott Laboratories⁸
Apr 24, 2026Granted 2,286 shares of Abbott Laboratories⁸
Feb 4, 2026Bought 5,033 shares at $108.33 of Abbott Laboratories⁹
Feb 4, 2026Bought 4,967 shares at $109.14 of Abbott Laboratories⁹
Apr 25, 2025Granted 1,635 shares of Abbott Laboratories¹⁰
Apr 26, 2024Granted 1,866 shares of Abbott Laboratories¹¹
Oct 26, 2023Sold 23,093 shares at $94.33 of Abbott Laboratories¹²
Oct 26, 2023Sold 26,907 shares at $93.81 of Abbott Laboratories¹²
Jul 27, 2023Sold 29,066 shares at $114.01 of Abbott Laboratories¹³
Jul 27, 2023Sold 20,934 shares at $113.43 of Abbott Laboratories¹³
May 2, 2023Sold 3,452 shares at $111.75 of Abbott Laboratories¹⁴
May 2, 2023Sold 46,548 shares at $110.97 of Abbott Laboratories¹⁴
Apr 28, 2023Granted 1,816 shares of Abbott Laboratories¹⁴
Oct 27, 2022Sold 9,313 shares at $98.14 of Abbott Laboratories¹⁵
Oct 27, 2022Sold 40,687 shares at $97.30 of Abbott Laboratories¹⁵
Jul 26, 2022Sold 22,251 shares at $109.60 of Abbott Laboratories¹⁶
Jul 26, 2022Sold 27,749 shares at $108.77 of Abbott Laboratories¹⁶
May 3, 2022Sold 6,123 shares at $114.84 of Abbott Laboratories¹⁷
May 3, 2022Sold 27,055 shares at $113.29 of Abbott Laboratories¹⁷
May 3, 2022Sold 16,822 shares at $112.51 of Abbott Laboratories¹⁷
Apr 29, 2022Granted 1,602 shares of Abbott Laboratories¹⁸
Apr 23, 2021Granted 1,499 shares of Abbott Laboratories¹⁹
Apr 24, 2020Granted 1,974 shares of Abbott Laboratories²⁰
Apr 26, 2019Granted 2,241 shares of Abbott Laboratories²¹
Apr 27, 2018Granted 2,945 shares of Abbott Laboratories²²

Trade performance

Date	Stock	Trade	Value	Return since	Vs S&P since	Vs S&P, 1 year
Apr 27, 2026	ABT	Buy	$926.5K	+13.0%	+5.1%
Feb 4, 2026	ABT	Buy	$1.1M	−3.1%	−15.5%
Oct 26, 2023	ABT	Sale	$4.7M	+11.6%	+75.5%	+18.8%
Jul 27, 2023	ABT	Sale	$5.7M	−6.9%	+77.5%	+26.9%
May 2, 2023	ABT	Sale	$5.6M	−5.9%	+93.8%	+26.5%
Oct 27, 2022	ABT	Sale	$4.9M	+8.2%	+94.9%	+12.3%
Jul 26, 2022	ABT	Sale	$5.5M	−3.9%	+101.3%	+12.0%
May 3, 2022	ABT	Sale	$5.7M	−6.7%	+92.1%	−1.4%

Returns are price-only (no dividends), measured from the trade date.

Career

Occupation: businessperson.⁶

Since 2017Board member, Abbott Laboratories⁴
2004 to 2016Chief executive officer^{3 5}
1996 to 2017Worked at St. Jude Medical^{2 3}

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataDaniel Starks on Wikidata
2
WikidataDaniel Starks: Worked at St. Jude Medical, on Wikidata
3
WikidataWorked at St. Jude Medical, as reported by proxy statement
4
WikidataDaniel Starks: Board member, Abbott Laboratories, on Wikidata
5
WikidataDaniel Starks: Chief executive officer, on Wikidata
6
WikidataDaniel Starks: occupation, on Wikidata
7
Wikidata and SEC EDGARAbbott Laboratories, Board member
8
SEC EDGARAbbott Laboratories shares after the filing of Apr 28, 2026
9
SEC EDGARForm 4 filed Feb 6, 2026
10
SEC EDGARForm 4 filed Apr 29, 2025
11
SEC EDGARForm 4 filed Apr 30, 2024
12
SEC EDGARForm 4 filed Oct 30, 2023
13
SEC EDGARForm 4 filed Jul 28, 2023
14
SEC EDGARForm 4 filed May 2, 2023
15
SEC EDGARForm 4 filed Oct 31, 2022
16
SEC EDGARForm 4 filed Jul 28, 2022
17
SEC EDGARForm 4 filed May 5, 2022
18
SEC EDGARForm 4 filed May 3, 2022
19
SEC EDGARForm 4 filed Apr 27, 2021
20
SEC EDGARForm 4 filed Apr 28, 2020
21
SEC EDGARForm 4 filed Apr 30, 2019
22
SEC EDGARForm 4 filed May 1, 2018